2024 UK and Ireland modified Delphi consensus on myopia management in children and young people.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dahlmann-Noor Annegret H, Ghorbani-Mojarrad Neema, Williams Katie M, Ghoneim Ahmed, Allen Peter M, Beach Michelle L, Bruce Gillian, Buckhurst Hetal D, Buckhurst Phillip J, Cruickshank Fiona E, Cufflin Matthew P, Day Mhairi D, Doyle Lesley, Evans Bruce J W, Flitcroft Daniel Ian, Gray Lyle S, Grewal Indie, Guggenheim Jeremy A, Hammond Christopher J, Higginbotham Jason C, Jawaid Imran, Kearney Stephanie, Lawrenson John G, Logan Nicola S, Loughman James, Mallen Edward A H, McCullough Sara J, Nagra Manbir, Saunders Kathryn J, Seidel Dirk, Shah Tanvi, Strang Niall C, Webber Kathryn J, Wolffsohn James S, Young Alexandra L
Аннотация
METHODS: A modified Delphi consensus was conducted with a panel of 34 optometrists and ophthalmologists with expertise in myopia management.
RESULTS: Two rounds of voting took place and 131 statements were agreed, including that interventions should be discussed with parents/carers of all CYP who develop myopia before the age of 13 years, a recommendation for interventions to be publicly funded for those at risk of fast progression and high myopia, that intervention selection should take into account the CYP's hobbies and lifestyle and that additional training for eye care professionals should be available from non-commercial sources. Topics for which published evidence is limited or lacking were areas of weaker or no consensus. Modern myopia management contact and spectacles are suitable first-line treatments. The role and provision of low-concentration atropine needs to be reviewed once marketing authorisations and funding decisions are in place. There is some evidence that a combination of low-concentration atropine with an optical intervention can have an additive effect; further research is needed. Once an intervention is started, best practice is to monitor non-cycloplegic axial length 6 monthly.
CONCLUSION: Research is needed to identify those at risk of progression, the long-term effectiveness of individual and combined interventions, and when to discontinue treatment when myopia has stabilised. As further evidence continues to emerge, this consensus work will be repeated to ensure it remains relevant.